AGE-RELATED MORPHINE KINETICS IN INFANTS

被引:63
作者
POKELA, ML
OLKKOLA, KT
SEPPALA, T
KOIVISTO, M
机构
[1] UNIV HELSINKI,DEPT ANAESTHESIA,HELSINKI,FINLAND
[2] NATL PUBL HLTH INST,PHARMACOL & TOXICOL LAB,HELSINKI,FINLAND
来源
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 1993年 / 20卷 / 1-2期
关键词
MORPHINE; PHARMACOKINETICS; AGE-RELATED MORPHINE KINETICS; NEONATES; INFANTS;
D O I
10.1159/000457538
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of morphine was studied in 27 infants receiving a single intravenous dose of 0.1 mg/kg morphine after surgery (n = 23) or during mechanical ventilation (n = 4). The pharmacokinetics of morphine varied greatly between the subjects, especially in the neonates. The clearance and half-life varied distinctly with postnatal age. The mean ( SD) half-life was 8.1 +/- 8.1 h in 10 neonates younger than 1 week, 5.4 +/- 3.4 h in 10 infants aged from 1 week to 2 months and 2.6 +/- 1.7 h in 7 infants aged from 2 to 6 months. Mean clearance increased significantly with age, being 8.7 +/- 5.8 ml/min/kg in the youngest age group, 11.9 +/- 5.1 ml/min/kg in those aged 1 week to 2 months and 28.0 +/- 8.9 ml/min/kg in those aged 2-6 months, and was also significantly lower in the critically ill infants. The clearance and half-life of morphine begin to approach adult values after the age of 1 month, but great individual variability exists even after that. In order to reduce the risk of overdosing or underdosing, the dose of morphine should be titrated individually.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 28 条
[1]   MORPHINE KINETICS AFTER DIAMORPHINE INFUSION IN PREMATURE NEONATES [J].
BARRETT, DA ;
ELIASJONES, AC ;
RUTTER, N ;
SHAW, PN ;
DAVIS, SS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :31-37
[2]  
BARRIER G, 1989, INTENS CARE MED, V15, P37
[3]   MORPHINE-METABOLISM IN ACUTELY ILL PRETERM NEWBORN-INFANTS [J].
BHAT, R ;
ABUHARB, M ;
CHARI, G ;
GULATI, A .
JOURNAL OF PEDIATRICS, 1992, 120 (05) :795-799
[4]   PHARMACOKINETICS OF A SINGLE DOSE OF MORPHINE IN PRETERM INFANTS DURING THE 1ST WEEK OF LIFE [J].
BHAT, R ;
CHARI, G ;
GULATI, A ;
ALDANA, O ;
VELAMATI, R ;
BHARGAVA, H .
JOURNAL OF PEDIATRICS, 1990, 117 (03) :477-481
[5]  
BHATTMEHTA V, 1991, CLIN PHARMACY, V10, P667
[6]  
BOREUS LO, 1982, PRINCIPLES PEDIATRIC, P46
[7]   PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF MORPHINE IN NEONATES [J].
CHAY, PCW ;
DUFFY, BJ ;
WALKER, JS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (03) :334-342
[8]   MORPHINE-METABOLISM IN NEONATES AND INFANTS [J].
CHOONARA, I ;
LAWRENCE, A ;
MICHALKIEWICZ, A ;
BOWHAY, A ;
RATCLIFFE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (05) :434-437
[9]   MORPHINE-METABOLISM IN CHILDREN [J].
CHOONARA, IA ;
MCKAY, P ;
HAIN, R ;
RANE, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) :599-604
[10]  
DAHLSTROM B, 1979, CLIN PHARMACOL THER, V26, P354